Skip to main content
. Author manuscript; available in PMC: 2021 Jul 16.
Published in final edited form as: Curr Hematol Malig Rep. 2021 Mar 30;16(2):126–131. doi: 10.1007/s11899-021-00627-3

Table 1.

Adverse event reporting challenges and potential solutions

Challenges Solutions
Variation in training and background education on AE reporting
  • Increase availability of training regarding AE reporting for clinical research associates

  • Provide training for clinicians on CTCAE and documenting AEs in the chart

  • Provide additional guidance on interpreting AE definitions to account for variation in medical knowledge

AE reporting is labor intensive
  • Implement automated extraction of electronic health record data to identify AEs, for example, a tool such as ExtractEHR

  • Incorporate trigger tools and alert systems into the EHR so that clinicians, CRAs, and research nurses are alerted to potential AEs that need to be reported

  • Create an automated system to move data from the EHR into the clinical trial data capture system

  • Limit the scope of AEs required to be collected on clinical trials

Complexity of the CTCAE
  • Streamline AE definitions to reduce potentially overlapping definitions and subjectivity in definitions

  • Provide guidance about comprehensiveness of AE reporting (i.e. to report the syndrome and the individual symptoms or to report just the syndrome)

  • Add more pediatric-specific guidance for AE definitions

Current AE reporting does not provide a complete understanding of AE experienced
  • Incorporate methods to capture duration of AEs rather than only the highest grade, such as ToxT

  • Include patient-reported outcome measures into clinical trials to supplement clinician-identified AEs

AE, adverse event; CRA, clinical research associate; CTCAE, Common Terminology Criteria for Adverse Events; EHR, electronic health record; ToxT, toxicity over time